Navigation Links
Molecules can block breast cancer's ability to spread
Date:1/9/2008

Researchers have identified a specific group of microRNA molecules that are responsible for controlling genes that cause breast cancer metastasis. The study, led by scientists at Memorial Sloan-Kettering Cancer Center (MSKCC), appears in the January 10, 2008, issue of Nature.

MicroRNAs are known to inhibit the activity of entire sets of genes associated with cancer metastasis a process that leads to the majority of cancer-related deaths. The new work explains how the loss of certain microRNAs allows cancer cells to migrate through organ tissue and to grow more rapidly.

The researchers examined human breast cancer cells with strong metastatic ability and found that the cells had lost large numbers of three different microRNA molecules. Conversely, when researchers put those molecules back into human breast cancer tumors in mice, the tumors lost their ability to spread.

In addition, the researchers looked at breast cancer patients and discovered that those with tumors that had lost these molecules were much more likely to suffer from cancer metastasis to the lung and bone.

The identification of molecules that inhibit a cells metastatic potential may help guide clinical decision-making in the future by enabling oncologists to more accurately identify patients at highest risk for metastatic relapse, said the studys lead author Sohail Tavazoie, MD, PhD, a postdoctoral fellow in the Oncology-Hematology Fellowship program at MSKCC.

In further analyzing one of these microRNAs, called miR-335, investigators found that miR-335 works by suppressing certain genes that are associated with human metastasis, particularly SOX4, which acts as a transcription factor (meaning that it regulates a group of genes responsible for cell development and migration), and tenascin-C, which functions outside the cell in what is called the extracellular matrix and is implicated in cell migration.

We now have a better understanding of the role this molecular pathway plays as a suppressor of breast cancers ability to spread to the lung and bone, and we have identified the genes involved in that process. These findings may enhance our ability to come up with more effective drugs to prevent or treat cancer metastasis, said Joan Massagu, PhD, Chair of the Cancer Biology and Genetics Program at MSKCC, a Howard Hughes Medical Institute Investigator, and the studys senior author.


'/>"/>

Contact: Esther Napolitano
napolite@mskcc.org
212-639-3573
Memorial Sloan-Kettering Cancer Center
Source:Eurekalert

Related medicine news :

1. Major Advance in the Observation of DNA Molecules
2. Researchers identify molecules with interesting anti-clotting properties
3. Study Describes Molecules That Control Blood Pressure
4. New class of RNA molecules may be important in human cancer
5. Forever young: Differentiation blocked in tumor stem cells
6. FDA approves Bystolic, a novel beta blocker
7. Blood-vessel blocker aids cancer-killing virus
8. Study Finds a Lack of Health Insurance May Roadblock Some Diabetes Patients From Seeking Critical Treatment
9. Grape powder blocks genes linked to colon cancer
10. Blocking Potent Oxidant Could Prevent Morphine Tolerance
11. Conseco Completes Divestiture of Old Block of Fixed and Equity-Indexed Annuities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... June 20, 2017 , ... Dr. Manju ... OH for leading-edge care, whether or not they have a referral. Dr. Kejriwal ... WaterLase® iPlus™ laser, she targets bacteria and damaged tissue without affecting the surrounding ...
(Date:6/20/2017)... PA (PRWEB) , ... June 20, 2017 , ... ... at Allegheny Health Network’s (AHN) Jefferson Hospital is providing physicians with advanced capabilities ... scanner provides higher-resolution images than traditional MRIs, enabling doctors to get a more ...
(Date:6/20/2017)... ... June 20, 2017 , ... In ... Stevia Sweetener, Michael P. May, Ph.D., recently accepted the distinguished Sun Corridor Export ... selected Wisdom Natural Brands (WNB), and 16 other businesses from Pima, Pinal, and ...
(Date:6/20/2017)... , ... June 20, 2017 , ... ... agency, recently became re-accredited by the Joint Commission, which accredits and ... accreditation and certification is recognized nationwide as a symbol of quality that reflects ...
(Date:6/20/2017)... ... 20, 2017 , ... MEDI+SIGN, a healthcare technology company that ... Stanowski, DHA, FACHE to the MEDI+SIGN Advisory Board. , “We are eager ... provide invaluable direction for the company,” says Andrew Hoffman, President of MEDI+SIGN. ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... years ago today, the Monterey Pop Festival opened its gates ... Francisco "Summer of Love."  To celebrate the anniversary, Northern Light® ... market research portals that it will begin delivering to customers ... "Summer of Love (For Our Customers)."  ... Northern Light ...
(Date:6/14/2017)... June 14, 2017 The Bio Supply Management ... City of Fremont and the Biomedical Manufacturing ... industry in California by providing ... networking, and fostering workforce development. The primary focus of ... of start-ups, as well as small and mid-sized biomedical ...
(Date:6/13/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... U.S. Food and Drug Administration (FDA) has notified the Company ... its Zhejiang, China manufacturing facility has ... successful clearance of the Warning Letter related to our ... measure of the progress we have made in our ongoing ...
Breaking Medicine Technology: